Rodriguez-Vida, A: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

Powles, Thomas, Kockx, Mark, Rodriguez-Vida, Alejo, Duran, Ignacio, Crabb, Simon J., Van Der Heijden, Michiel S., Szabados, Bernadett, Pous, Albert Font, Gravis, Gwenaelle, Herranz, Urbano Anido, Prot

Journal:

Nature Medicine

Year:

2019

Language:

english

File:

PDF, 7.82 MB

english, 2019

2

Immunotherapy Combinations and Sequences in Urothelial Cancer: Facts and Hopes

Rodriguez-Vida, Alejo, Pérez-Gracia, José Luis, Bellmunt, Joaquim

Journal:

Clinical Cancer Research

Year:

2018

Language:

english

File:

PDF, 776 KB

english, 2018

3

The TRITON clinical trial programme: evaluation of the PARP inhibitor rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD)

Rodriguez-Vida, A., Arranz Arija, J.A., Daugaard, G., Fizazi, K., Gez, E., Heidenreich, A., Joly, F., Krieger, L., Mcdermott, R., Merseburger, A.S., Piulats, J.M., Sautois, B., Shapiro, J., Sridhar, S

Journal:

European Urology Supplements

Year:

2017

Language:

english

File:

PDF, 75 KB

english, 2017

4

CtDNA as a predictor of outcome in patients treated with neoadjuvant atezolizumab in muscle invasive urothelial cancer

Powles, T, Szabados, B, Castellano, D, Rodriguez-Vida, A, Valderrama, B, Crabb, S, Van Der Heijden, M, Pous, AF, Prendergast, A, Gravis, G, Herranz, UA, Sharma, S, Ravauld, A, Sethi, H, Zimmerman, B,

Journal:

Urologic Oncology: Seminars and Original Investigations

Year:

2020

File:

PDF, 5.50 MB

2020

5

The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as biomarker of taxane resistance in castration-resistant prostate cancer

Marín-Aguilera, Mercedes, Reig, Òscar, Milà-Guasch, Maria, Font, Albert, Domenech, Montserrat, Rodríguez-Vida, Alejo, Carles, Joan, Suárez, Cristina, González del Alba, Aránzazu, Jiménez, Natalia, Vic

Journal:

International Journal of Cancer

Year:

2019

Language:

english

File:

PDF, 1.85 MB

english, 2019

6

Novel oral mTORC1/2 inhibitor TAK-228 has synergistic antitumor effects when combined with paclitaxel or PI3Kα inhibitor TAK-117 in preclinical bladder cancer models

Hernández-Prat, Anna, Rodriguez-Vida, Alejo, Juanpere-Rodero, Nuria, Arpí, Oriol, Menéndez, Silvia, Soria-Jimenez, Luis, Martínez, Alejandro, Iarchouk, Natalia, Rojo, Federico, Albanell, Joan, Brake,

Journal:

Molecular Cancer Research

Year:

2019

Language:

english

File:

PDF, 11.53 MB

english, 2019

7

954PSPAZO2 (SOGUG): Outcomes and prognostic significance of IMDC intermediate prognosis subclassification in metastatic renal cell carcinoma (mRCC) in patients treated with 1st-line pazopanib (1stPz)

Valderrama, B P, Perez Ramirez, S, Rodriguez-Vida, A, González del Alba, A, Mendez Vidal, M J, Vazquez Estevez, S, Martinez Ortega, E, Virizuela, J A, Fernández Calvo, O, Hernández Jorge, A, Vazquez M

Journal:

Annals of Oncology

Year:

2019

Language:

english

File:

PDF, 93 KB

english, 2019

8

Causes of death in men with prostate cancer: an analysis of 50 000 men from the Thames Cancer Registry

Chowdhury, Simon, Robinson, David, Cahill, Declan, Rodriguez-Vida, Alejo, Holmberg, Lars, Møller, Henrik

Journal:

BJU International

Year:

2013

Language:

english

File:

PDF, 344 KB

english, 2013

9

Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities

Martínez-Bosch, Neus, Rodriguez-Vida, Alejo, Juanpere, Núria, Lloreta, Josep, Rovira, Ana, Albanell, Joan, Bellmunt, Joaquim, Navarro, Pilar

Journal:

Nature Reviews Urology (formerly Nature Clinical Practice Urology)

Year:

2019

Language:

english

File:

PDF, 1.69 MB

english, 2019

10

ATLAS: A phase 2, open-label study of rucaparib in patients with locally advanced or metastatic urothelial carcinoma

Rodriguez-Vida, A., Feyerabend, S., Loriot, Y., Necchi, A., Gupta, S., Josephs, D., Srinivas, S., Zakharia, Y., Nepert, D., Wride, K., Thomas, D., Dusek, R., Simmons, A., Grivas, P., Chowdhury, S.

Journal:

European Urology Supplements

Year:

2019

File:

PDF, 111 KB

2019

11

917TiPPhase II study of paclitaxel and TAK-228 in metastatic urothelial carcinoma and the impact of PI3K-mTOR pathway genomic alterations

Rodríguez-Vida, A, Pérez-Gracia, J L, Taus, A, Bonfill, T, Vázquez-Mazón, F J, Galtes, S, Pons, B, Cano, L, Macia, S, Maroto, P, Bellmunt, J

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 83 KB

english, 2018

12

Avelumab for the treatment of urothelial cancer

Rodriguez-Vida, Alejo, Bellmunt, Joaquim

Journal:

Expert Review of Anticancer Therapy

Year:

2018

Language:

english

File:

PDF, 1.07 MB

english, 2018

13

917TiPPhase II study of paclitaxel and TAK-228 in metastatic urothelial carcinoma and the impact of PI3K-mTOR pathway genomic alterations

Rodríguez-Vida, A, Pérez-Gracia, J L, Taus, A, Bonfill, T, Vázquez-Mazón, F J, Galtes, S, Pons, B, Cano, L, Macia, S, Maroto, P, Bellmunt, J

Journal:

Annals of Oncology

Year:

2018

File:

PDF, 83 KB

2018

14

Is there an antiandrogen withdrawal syndrome with enzalutamide?

Rodriguez-Vida, Alejo, Bianchini, Diletta, Van Hemelrijck, Mieke, Hughes, Simon, Malik, Zafar, Powles, Thomas, Bahl, Amit, Rudman, Sarah, Payne, Heather, de Bono, Johann, Chowdhury, Simon

Journal:

BJU International

Year:

2015

Language:

english

File:

PDF, 259 KB

english, 2015

15

281 small cell bladder cancer analysis from spanish institutions

Fita, M.J. Juan, Ramirez-Backhaus, M., Puntí, X. Bonet, Gomez, J., Ramos, E., Pesquera, L., Rodriguez-Vida, A., Viscasillas, I. Lacasa, Guzman, J.C. Villa, Sanchez-Salas, R., Sanchez, J.L. Sanchez, Mi

Journal:

Annals of Oncology

Year:

2016

File:

PDF, 66 KB

2016

16

Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

Powles, Thomas, Kockx, Mark, Rodriguez-Vida, Alejo, Duran, Ignacio, Crabb, Simon J., Van Der Heijden, Michiel S., Szabados, Bernadett, Pous, Albert Font, Gravis, Gwenaelle, Herranz, Urbano Anido, Prot

Journal:

Nature Medicine

Year:

2020

File:

PDF, 1.01 MB

2020

17

Serum lipids as markers of prostate cancer occurrence and prognosis?

Arthur, Rhonda, Rodríguez-Vida, Alejo, Zadra, Giorgia, Møller, Henrik, Van Hemelrijck, Mieke

Journal:

Clinical Lipidology

Year:

2015

Language:

english

File:

PDF, 899 KB

english, 2015

18

899PA phase II study investigating the safety and efficacy of neoadjuvent atezolizumab in muscle invasive bladder cancer (ABACUS)

Castellano, D, Duran, I, Rodríguez-Vida, A, Crabb, S J, van der Heijden, M S, Font Pous, A, Gravis, G, Anido Herranz, U, Protheroe, A, Ravaud, A, Maillet, D, Mendez-Vidal, M J, Suarez, C, Lorch, A, St

Journal:

Annals of Oncology

Year:

2018

File:

PDF, 79 KB

2018

19

18F-FDG-PET/CT Imaging as Survival Predictor in Patients with Metastatic Uveal Melanoma

Rodriguez-Vida, A., MuÃ±oz, E., de Olza, M. Ochoa, Rossi, S., Gamez, C., Caminal, J.M., Perez, J., Cortes, J., Piulats, J.M.

Journal:

Annals of Oncology

Year:

2012

File:

PDF, 60 KB

2012

20

175 Identification of Inhibitors with Specificity for Breast Cancer Cells with Acquired Resistance to Endocrine Treatment

Aguilar, H., Halonen, P., Serra-Musach, J., Rodríguez-Vida, A., Tirado, O.M., Beijersbergen, R.L., Urruticoechea, A., Pujana, M.A.

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 56 KB

english, 2012

21

Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinoma: Table 1

Rodriguez-Vida, Alejo, Strijbos, Michiel, Hutson, Thomas

Journal:

Year:

2016

Language:

english

File:

PDF, 1.13 MB

english, 2016

22

826PPrevalence and baseline clinico-pathological associations of germline deleterious mutations in DNA repair genes (gmDDR) in a metastatic castration resistant prostate cancer (mCRPC) prospective spanish cohort (PROREPAIR-B study)

Romero Laorden, N., Lozano Mejorada, R., Piulats Rodriguez, J.M., Vallespín, E., Montesa, A., Lorente Estelles, D., Villaguzmán, J.C., Grau, G., Rodriguez-Vida, A., Ibañez, K., Gonzalez-Billalabeitia,

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 96 KB

english, 2017

23

Enzalutamide for the treatment of metastatic castration-resistant prostate cancer

Rodriguez-Vida, Alejo, Chowdhury, Simon, Sternberg, Cora, Rudman, Sarah, Galazi, Myria

Journal:

Drug Design Development and Therapy

Year:

2015

Language:

english

File:

PDF, 802 KB

english, 2015

24

New treatment options for metastatic renal cell carcinoma

Rodriguez-Vida, Alejo, Hutson, Thomas E, Bellmunt, Joaquim, Strijbos, Michiel H

Journal:

Year:

2017

Language:

english

File:

PDF, 863 KB

english, 2017

25

Mammalian target of rapamycin (mTOR)-related non-infectious pneumonitis: a potential biomarker of clinical benefit?

Rodriguez-Vida, Alejo, Chau, Noan-Minh, Chowdhury, Simon

Journal:

BJU International

Year:

2014

Language:

english

File:

PDF, 91 KB

english, 2014

26

Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer

Lorente, David, Bianchini, Diletta, Rodriguez-Vida, Alejo, Omlin, Aurelius, Pezaro, Carmel, Ferraldeschi, Roberta, Zivi, Andrea, Attard, Gerhardt, Chowdhury, Simon, De Bono, Johann S.

Journal:

European Journal of Cancer

Year:

2014

Language:

english

File:

PDF, 279 KB

english, 2014

27

1686PAbility of TMPRSS2-ERG (TE) expression to predict taxane benefit depending on prior abiraterone or enzalutamide therapy in castration-resistant prostate cancer

Marín-Aguilera, M., Reig, O., Font, A., Rodríguez-Vida, A., Suárez, C., Domenech, M., Jiménez, N., Victoria, I., López, S., Milà-Guasch, M., Felip, E., Etxaniz, O., Carles, J., Racca, F., Sala-Gonzále

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 67 KB

english, 2017

28

954PSPAZO2 (SOGUG): Outcomes and prognostic significance of IMDC intermediate prognosis subclassification in metastatic renal cell carcinoma (mRCC) in patients treated with 1st-line pazopanib (1stPz)

Valderrama, B P, Perez Ramirez, S, Rodriguez-Vida, A, González del Alba, A, Mendez Vidal, M J, Vazquez Estevez, S, Martinez Ortega, E, Virizuela, J A, Fernández Calvo, O, Hernández Jorge, A, Vazquez M

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 93 KB

2019

29

Cell Plasticity-Related Phenotypes and Taxanes Resistance in Castration-Resistant Prostate Cancer

JimÃ©nez, Natalia, Reig, Ãscar, Montalbo, Ruth, MilÃ -Guasch, Maria, Nadal-Dieste, Lluis, Castellano, Giancarlo, Lozano, Juan JosÃ©, Victoria, IvÃ¡n, Font, Albert, Rodriguez-Vida, Alejo, Carles, Joan

Journal:

Frontiers in Oncology

Year:

2020

File:

PDF, 3.72 MB

2020

30

Some unfairness in classifying dental schools

Lorente, David, Bianchini, Diletta, Rodriguez-Vida, Alejo, Omlin, Aurelius, Pezaro, Carmel, Ferraldeschi, Roberta, Zivi, Andrea, Attard, Gerhardt, Chowdhury, Simon, De Bono, Johann S.

Journal:

International Journal of Orthodontia and Oral Surgery (1919)

Year:

1920

Language:

english

File:

PDF, 239 KB

english, 1920

31

Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities

Martínez-Bosch, Neus, Rodriguez-Vida, Alejo, Juanpere, Núria, Lloreta, Josep, Rovira, Ana, Albanell, Joan, Bellmunt, Joaquim, Navarro, Pilar

Journal:

Nature Reviews Urology (formerly Nature Clinical Practice Urology)

Year:

2019

File:

PDF, 1.69 MB

2019

32

Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone

Bianchini, D., Lorente, D., Rodriguez-Vida, A., Omlin, A., Pezaro, C., Ferraldeschi, R., Zivi, A., Attard, G., Chowdhury, S., de Bono, J.S.

Journal:

European Journal of Cancer

Year:

2014

Language:

english

File:

PDF, 469 KB

english, 2014

33

Cytoreductive nephrectomy: past, present and future

Galazi, Myria, Rodriguez-Vida, Alejo, Josephides, Eleni, Chau, Noan-Minh, Chowdhury, Simon

Journal:

Expert Review of Anticancer Therapy

Year:

2014

Language:

english

File:

PDF, 368 KB

english, 2014

34

Genomic predictors of good outcome, recurrence or progression in High grade T1 non-muscle invasive bladder cancer

Bellmunt, Joaquim, Kim, Jaegil, Reardon, Brendan, Perera-Bel, JÃºlia, Orsola, Anna, Rodriguez-Vida, Alejo, Wankowicz, Stephanie A., Bowden, Michaela, Barletta, Justine A, Morote, Juan, de Torres, InÃ©

Journal:

Cancer Research

Year:

2020

File:

PDF, 4.11 MB

2020

35

Complexity of FGFR signalling in metastatic urothelial cancer

Rodriguez-Vida, Alejo, Saggese, Matilde, Hughes, Simon, Rudman, Sarah, Chowdhury, Simon, Smith, Neil R., Lawrence, Peter, Rooney, Claire, Dougherty, Brian, Landers, Donal, Kilgour, Elaine, Arkenau, He

Journal:

Journal of Hematology & Oncology

Year:

2015

Language:

english

File:

PDF, 2.32 MB

english, 2015

36

Management of fatigue and anaemia in men treated with androgen deprivation therapy

Rodriguez-Vida, Alejo, Chowdhury, Subhra, Chowdhury, Simon

Journal:

Trends in Urology & Men's Health

Year:

2014

Language:

english

File:

PDF, 120 KB

english, 2014

37

899PA phase II study investigating the safety and efficacy of neoadjuvent atezolizumab in muscle invasive bladder cancer (ABACUS)

Castellano, D, Duran, I, Rodríguez-Vida, A, Crabb, S J, van der Heijden, M S, Font Pous, A, Gravis, G, Anido Herranz, U, Protheroe, A, Ravaud, A, Maillet, D, Mendez-Vidal, M J, Suarez, C, Lorch, A, St

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 79 KB

english, 2018

38

928TiPATLAS: A phase II, open-label study of rucaparib in patients (pts) with locally advanced (unresectable) or metastatic urothelial carcinoma

Chowdhury, S, Feyerabend, S, Loriot, Y, Necchi, A, Gupta, S, Josephs, D H, Rodríguez-Vida, A, Srinivas, S, Zakharia, Y, Nepert, D, Wride, K, Thomas, D, Loehr, A, Simmons, A D, Grivas, P

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 77 KB

english, 2018

39

The role of metastasectomy in renal cell carcinoma

Josephides, Eleni, Rodriguez-Vida, Alejo, Galazi, Myria, Chowdhury, Simon, Suder, Aneta

Journal:

Expert Review of Anticancer Therapy

Year:

2013

Language:

english

File:

PDF, 263 KB

english, 2013

40

920TiPAfatinib in patients with advanced or metastatic urothelial carcinoma (UC) with genetic alterations in ErbB receptors 1–3 who failed on platinum-based chemotherapy: The Phase II LUX-Bladder 1 trial

Font, A., Real, F.X., Puente, J., Vazquez Mazon, F.J., Sala, N., Virizuela, J.A., Rodriguez-Vida, A., Grande Pulido, E., Castellano, D., Climent, M.A., Gallardo, E., González del Alba, A., Fernandez,

Journal:

Annals of Oncology

Year:

2017

File:

PDF, 81 KB

2017

41

Precision medicine for prostate cancer

Galazi, Myria, Rodriguez-Vida, Alejo, Ng, Tony, Mason, Malcolm, Chowdhury, Simon

Journal:

Expert Review of Anticancer Therapy

Year:

2014

Language:

english

File:

PDF, 474 KB

english, 2014

42

Selection and monitoring of patients with metastatic castration-resistant prostate cancer for treatment with radium-223

Rodriguez-Vida, A., Torregrosa, M. D., Pinto, Á., Climent, M. Á., Olmos, D., Carles, J.

Journal:

Clinical and Translational Oncology

Year:

2017

Language:

english

File:

PDF, 544 KB

english, 2017

43

Randomised phase II study comparing alternating cycles of sunitinib and everolimus versus standard sequential administration in first-line metastatic renal carcinoma (SUNRISES study)

Rodriguez-Vida, Alejo, Bamias, Aristotelis, Esteban, Emilio, Saez, Maria Isabel, Lopez-Brea, Marta, Castellano, Daniel, Caballero, Cristina, Luis Gonzalez-Larriba, Jose, Calvo, Emiliano, Macia, Sonia,

Journal:

BJU International

Year:

2020

File:

PDF, 11.97 MB

2020

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски